Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/15/2021 06/16/2021 06/17/2021 06/18/2021 06/21/2021 Date
164.49(c) 164.43(c) 165.22(c) 161.98(c) 163.84 Last
5 063 027 6 988 477 5 874 962 12 993 018 6 588 663 Volume
-0.53% -0.04% +0.48% -1.96% +1.15% Change
More quotes
Financials (USD)
Sales 2021 92 812 M - -
Net income 2021 22 227 M - -
Net Debt 2021 314 M - -
P/E ratio 2021 19,5x
Yield 2021 2,58%
Sales 2022 97 460 M - -
Net income 2022 23 302 M - -
Net cash position 2022 7 133 M - -
P/E ratio 2022 17,9x
Yield 2022 2,73%
Capitalization 427 B 427 B -
EV / Sales 2021 4,60x
EV / Sales 2022 4,30x
Nbr of Employees 134 500
Free-Float 84,3%
More Financials
Company
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care,... 
Sector
Pharmaceuticals
Calendar
06/23 | 08:00amSpecial Situation
More about the company
Ratings of Johnson & Johnson
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about JOHNSON & JOHNSON
10:43aJOHNSON & JOHNSON  : How Johnson & Johnson Helped Us Adopt 11 Children
AQ
06/19MODERNA  : U.S. administers more than 317 mln doses of COVID-19 vaccines - CDC
RE
06/18The Week Ahead -- Barron's
DJ
06/17JOHNSON & JOHNSON  : Eying border reopening, Mexico begins J&J vaccine rollout i..
AQ
06/17Canada Vaccine Panel Recommends Against AstraZeneca PLC for Second Dose
DJ
06/17US to Spend $3.2 Billion on COVID Treatments Research
MT
06/16ASTRAZENECA  : Second Phase of Covid-19 Vaccinations Begins
AQ
06/16EU Says Johnson & Johnson May Not Meet Vaccine Supply Commitment After Jabs C..
MT
06/15US, EU Vow to Provide COVID-19 Vaccine to Two-Thirds of World's Population by..
MT
06/15JOHNSON & JOHNSON  : Aspen to Dispatch 300 000 J&J Vaccines for Teachers
AQ
06/15JOHNSON & JOHNSON  : Donated US vaccines arrive for Mexican border cities
AQ
06/15THE LATEST : Johnson & Johnson shots arrive in Mexico from US
AQ
06/15FEDEX  : Makes its First COVID-19 Vaccine Delivery to Mexico, of 1.35 Million Jo..
MT
06/15FedEx Delivers 1.35 Million J&J Covid-19 Vaccine Doses to Mexico
DJ
06/15JOHNSON & JOHNSON  : COVID-19 Vaccine Wins Emergency Use Approval In Malaysia
MT
More news
News in other languages on JOHNSON & JOHNSON
10:55aJ&J  : Ethicon présente un nouveau dispositif médical
06:09aIMPFUNGEN FÜR ALLE MÖGLICH : Eine Million Buchungen in Großbritannien
06/18Zuversicht bei Reisen und Impfen - Sorge vor Delta-Variante
06/18Hälfte der Bürger mindestens einmal gegen Corona geimpft
06/18SPAHN : Jeder zweite Bundesbürger mit erster Corona-Impfung
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 183,67 $
Last Close Price 161,98 $
Spread / Highest target 25,9%
Spread / Average Target 13,4%
Spread / Lowest Target -2,46%
EPS Revisions
Managers and Directors
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON2.92%426 557
ROCHE HOLDING AG12.70%325 803
PFIZER, INC.5.43%217 246
NOVARTIS AG2.47%208 642
ABBVIE INC.5.57%199 795
ELI LILLY AND COMPANY29.44%198 668